• Target

    £5,200,000

  • Type

    Other

  • Close Date

    TBC

  • Status

    Preview

RISK WARNING: Your capital is at risk. The risks of investing include: illiquidity; lack of dividends; loss of investment; and dilution. You should invest only as part of a diversified portfolio.
Please read FULL risk warning

Bioinduction Ltd

Bioinduction aims to make neurostimulation as mainstream as cardiac pacemakers are today: Stimulating the nervous system to replace drugs.

CAUTION: This project has not been approved as a financial promotion. No investment decisions about the project should be made on the basis of information provided on this platform.

Track
Contact
Companies
House
Twitter

Overview

Bioinduction is a UK-based group manufacturing unique implantable neuromodulation devices.

Our mission is:
  • To disrupt Deep Brain Stimulation (DBS) markets through the introduction of the Picostim technology, a neurostimulator 60% smaller than competitors and capable of implantation in around half the time. 
  • To leverage efficiency savings engendered by such a device by expanding into indications of scale such as drug resistant hypertension, stroke and vascular dementia, currently with high unmet need and targeted near-exclusively by Pharma. 

Deal Manager avatar

Deal Manager
Christopher Hill

This section is currently locked.
Please Sign Up or Log In to unlock.

Team

This section is currently locked.
Please Sign Up or Log In to unlock.

Market

This section is currently locked.
Please Sign Up or Log In to unlock.

Investment

This section is currently locked.
Please Sign Up or Log In to unlock.

Discussions

This section is currently locked.
Please Sign Up or Log In to unlock.

Documents

2 documents are currently locked.
To unlock the Public Data Room you will need to Sign Up or Login

Originator


Originator: SETsquared Partnership

Investment Focus: Equity

About: The SETsquared Partnership is the enterprise collaboration between the universities of Bath, Bristol, Exeter, Southampton and Surrey.

Contact Name: Jake Ronay

  • Registered Investors
    100 - 250
  • Investment through platform
    Up to £1m